Sanofi competitors

Sanofi Competitors include Regeneron Pharmaceuticals, Celgene, Retrophin and Palatin Technologies.
Add company...
Sanofi
Sanofi provides therapeutic solutions.
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals is a biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.
Celgene
Celgene Corporation is a biopharmaceutical company.
Retrophin
Retrophin is a biopharmaceutical company which focuses on the development, acquisition, and commercialization of therapies for the treatment of serious or rare diseases.
Palatin Technologies
Palatin Technologies is a biopharmaceutical company, developing targeted, receptor-specific peptide therapeutics for the treatment of various diseases.
Founding Date
Founding Date
2004
Founding Date
1988
Founding Date
1986
Founding Date
2011
Founding Date
1986
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Paris, FR HQ
Macquarie Park, AU
Ontario, CA
Beijing, CN
Hong Kong, HK
New Delhi, IN
Tokyo, JP
see more
Locations
Tarrytown, US HQ
Dublin, IE
Limerick, IE
Greater London, GB
Rensselaer, US
Bernards, US
Locations
Summit, US HQ
Singapore, SG
Boudry, CH
Locations
San Diego, US HQ
Dublin, IE
Cambridge, US
New York, US
Locations
Cranbury, US HQ
Employees
Employees
106,859
Employees
6,20015% increase
Employees
7,4675% increase
Employees
135
Employees
22
Valuation ($)
Valuation ($)
118.9 b
Valuation ($)
42.7 b
Valuation ($)
58.3 b
Valuation ($)
1 b
Valuation ($)
186.9 m
Facebook likes
Facebook likes
45.8 k
Facebook likes
3.9 k
Facebook likes
6.6 k
Facebook likes
N/A
Facebook likes
36
Twitter followers
Twitter followers
101.3 k
Twitter followers
12.6 k
Twitter followers
19.1 k
Twitter followers
486
Twitter followers
419

Financial

Revenue (est.)
Revenue (est.)
€37.1b (FY, 2015)
Revenue (est.)
$4.9b (FY, 2016)
Revenue (est.)
$13b (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
N/A
Cost of goods
Cost of goods
€10.9b (FY, 2015)
Cost of goods
$194.6m (FY, 2016)
Cost of goods
$461m (FY, 2017)
Cost of goods
$3.6m (FY, 2017)
Cost of goods
N/A
Gross profit
Gross profit
€26.1b (FY, 2015)
Gross profit
$4.7b (FY, 2016)
Gross profit
$12.5b (FY, 2017)
Gross profit
N/A
Gross profit
N/A
Net income
Net income
€4.4b (FY, 2015)
Net income
$895.5m (FY, 2016)
Net income
$2.9b (FY, 2017)
Net income
($59.7m) (FY, 2017)
Net income
$24.7m (FY, 2018)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 8.9m
Total funding raised
N/A
Total funding raised
$ 116m
Total funding raised
$ 104.2m
For sources of this data, please see the company profileDownload Excel

View company profiles

Regeneron Pharmaceuticals
HQ
Tarrytown, US
Employees
6,200↑ 15% increase

Regeneron Pharmaceuticals is a biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.

View company
Celgene
HQ
Summit, US
Employees
7,467↑ 5% increase

Celgene Corporation is a biopharmaceutical company.

View company
Retrophin
HQ
San Diego, US
Employees
135

Retrophin is a biopharmaceutical company which focuses on the development, acquisition, and commercialization of therapies for the treatment of serious or rare diseases.

View company
Palatin Technologies
HQ
Cranbury, US
Employees
22

Palatin Technologies is a biopharmaceutical company, developing targeted, receptor-specific peptide therapeutics for the treatment of various diseases.

View company